Showing results (1501-1510 of 1,623) with videos related to

Sort By:
Pageof 163
Biorxiv : the Preprint Server for Biology|June 4, 2025
Genetic Code Expansion and Enzymatic Modifications as Accessible Methods for Studying Site-Specific Post-Translational Modifications of Alpha-Synuclein and TauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 28, 2010
Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel diseaseMatthew J Walters, Yu Wang, Nu Lai, et al.
Cancer Gene Therapy|January 8, 2021
CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivoSu Jung Oh-Hohenhorst, Derya Tilki, Ann-Kristin Ahlers, et al.
Nature|August 27, 2025
The evolution of hominin bipedalism in two stepsGayani Senevirathne, Serena C Fernandopulle, Daniel Richard, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 27, 2020
Patient and Caregiver Perspectives on Terms Used to Describe Kidney HealthAllison Tong, Andrew S Levey, Kai-Uwe Eckardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 25, 2021
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer modelsClara Lemos, Volker K Schulze, Simon J Baumgart, et al.
Pageof 163